Trans-Activators
"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
Descriptor ID |
D015534
|
MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 | 1995 | 4 | 0 | 4 | 1996 | 4 | 3 | 7 | 1997 | 12 | 2 | 14 | 1998 | 5 | 3 | 8 | 1999 | 12 | 2 | 14 | 2000 | 7 | 3 | 10 | 2001 | 6 | 1 | 7 | 2002 | 6 | 4 | 10 | 2003 | 18 | 4 | 22 | 2004 | 25 | 15 | 40 | 2005 | 13 | 9 | 22 | 2006 | 9 | 8 | 17 | 2007 | 6 | 4 | 10 | 2008 | 7 | 3 | 10 | 2009 | 7 | 4 | 11 | 2010 | 6 | 10 | 16 | 2011 | 2 | 3 | 5 | 2012 | 6 | 6 | 12 | 2013 | 5 | 5 | 10 | 2014 | 4 | 3 | 7 | 2015 | 4 | 3 | 7 | 2016 | 1 | 4 | 5 | 2017 | 5 | 6 | 11 | 2018 | 3 | 3 | 6 | 2019 | 3 | 5 | 8 | 2020 | 4 | 3 | 7 | 2021 | 6 | 3 | 9 | 2022 | 0 | 4 | 4 | 2023 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
Wilkening RV, Langou?t-Astri? C, Severn MM, Federle MJ, Horswill AR. Identifying genetic determinants of Streptococcus pyogenes-host interactions in a murine intact skin infection model. Cell Rep. 2023 11 28; 42(11):113332.
-
Pijuan J, Moreno DF, Yahya G, Moisa M, Ul Haq I, Krukiewicz K, Mosbah R, Metwally K, Cavalu S. Regulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi. Microb Biotechnol. 2023 11; 16(11):2053-2071.
-
Bishop JA, Thompson LDR, Siegele B, Gagan J, Mansour M, Chernock RD, Rooper LM. Mucoepidermoid carcinoma may be devoid of squamoid cells by immunohistochemistry: expanding the histologic and immunohistochemical spectrum of MAML2- rearranged salivary gland tumours. Histopathology. 2023 Jan; 82(2):305-313.
-
Witkowski MT, Lee S, Wang E, Lee AK, Talbot A, Ma C, Tsopoulidis N, Brumbaugh J, Zhao Y, Roberts KG, Hogg SJ, Nomikou S, Ghebrechristos YE, Thandapani P, Mullighan CG, Hochedlinger K, Chen W, Abdel-Wahab O, Eyquem J, Aifantis I. NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia. Nat Immunol. 2022 10; 23(10):1424-1432.
-
Schleicher WE, Pietras EM. Reduced PU.1 Expression Collaborates with Tet2 Loss to Trigger Myeloid Leukemogenesis. Blood Cancer Discov. 2022 09 06; 3(5):378-381.
-
Furnish M, Boulton DP, Genther V, Grofova D, Ellinwood ML, Romero L, Lucia MS, Cramer SD, Caino MC. MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress Signaling. Mol Cancer Res. 2022 04 01; 20(4):607-621.
-
Kepple JD, Barra JM, Young ME, Hunter CS, Tse HM. Islet transplantation into brown adipose tissue can delay immune rejection. JCI Insight. 2022 02 22; 7(4).
-
Baker CR, Stewart JJ, Amstutz CL, Ching LG, Johnson JD, Niyogi KK, Adams WW, Demmig-Adams B. Genotype-dependent contribution of CBF transcription factors to long-term acclimation to high light and cool temperature. Plant Cell Environ. 2022 02; 45(2):392-411.
-
Ahmed N, Etzrodt M, Dettinger P, Kull T, Loeffler D, Hoppe PS, Chavez JS, Zhang Y, Camargo Ortega G, Hilsenbeck O, Nakajima H, Pietras EM, Schroeder T. Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation. J Exp Med. 2022 01 03; 219(1).
-
King HW, Wells KL, Shipony Z, Kathiria AS, Wagar LE, Lareau C, Orban N, Capasso R, Davis MM, Steinmetz LM, James LK, Greenleaf WJ. Integrated single-cell transcriptomics and epigenomics reveals strong germinal center-associated etiology of autoimmune risk loci. Sci Immunol. 2021 Oct 15; 6(64):eabh3768.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|